GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,420.60p
   
  • Change Today:
    -0.40p
  • 52 Week High: 2,263.00
  • 52 Week Low: 1,296.00
  • Currency: UK Pounds
  • Shares Issued: 4,094.93m
  • Volume: 3,348,756
  • Market Cap: £58,173m
  • RiskGrade: 129

Largest Deals (365 days)

Show trades greater than:
Traded Action Notifier PriceAmountValue
27-Jul-22 Sell Emma Walmsley 1,763.41p 148,525 £2,619,104.70
10-Feb-23 Sell Emma Walmsley 1,478.18p 176,689 £2,611,781.51
14-Feb-23 Sell Emma Walmsley 1,487.30p 28,576 £425,010.85
14-Feb-23 Sell Iain Mackay 1,488.87p 19,292 £287,232.79
08-Apr-22 Buy Dividends Emma Walmsley 1,741.00p 12,367 £215,309.47
10-Oct-22 Buy Dividends Emma Walmsley 1,322.60p 7,963 £105,318.64
12-Apr-22 Buy Dividends Hal Barron 3,592.15p 2,382 £85,583.58
18-Aug-22 Buy Dividends Hal Barron 1,435.16p 6,187 £88,793.11
23-Feb-23 Buy Hal Barron 1,467.27p 5,368 £78,763.13
19-May-22 Buy Hal Barron 1,746.58p 4,329 £75,609.36
17-Nov-22 Buy Dividends Hal Barron 1,373.07p 5,354 £73,513.97
23-Sep-22 Buy Charles Bancroft 1,429.93p 5,348 £76,472.55
07-Jul-22 Buy Dividends Hal Barron 2,169.68p 2,910 £63,137.69
11-Oct-22 Buy Dividends Emma Walmsley 1,357.18p 4,439 £60,245.22
12-Apr-22 Buy Dividends Emma Walmsley 1,784.37p 3,337 £59,538.75
20-Mar-23 Buy Charles Bancroft 1,405.33p 3,722 £52,306.26
17-Jan-23 Buy Dividends Emma Walmsley 1,436.37p 3,591 £51,580.05
08-Apr-22 Buy Dividends Hal Barron 1,773.25p 2,582 £45,785.27
23-Jun-22 Buy Charles Bancroft 1,697.32p 2,834 £48,102.07
12-Oct-22 Buy Dividends Hal Barron 1,378.25p 3,607 £49,713.50

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,420.60p
Change Today -0.40p
% Change -0.03 %
52 Week High 2,263.00
52 Week Low 1,296.00
Volume 3,348,756
Shares Issued 4,094.93m
Market Cap £58,173m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
69.7% below the market average69.7% below the market average69.7% below the market average69.7% below the market average69.7% below the market average
1.69% above the sector average1.69% above the sector average1.69% above the sector average1.69% above the sector average1.69% above the sector average
Price Trend
11.34% below the market average11.34% below the market average11.34% below the market average11.34% below the market average11.34% below the market average
49.21% above the sector average49.21% above the sector average49.21% above the sector average49.21% above the sector average49.21% above the sector average
Income
38.73% above the market average38.73% above the market average38.73% above the market average38.73% above the market average38.73% above the market average
77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average
Growth
51.77% below the market average51.77% below the market average51.77% below the market average51.77% below the market average51.77% below the market average
52.38% below the sector average52.38% below the sector average52.38% below the sector average52.38% below the sector average52.38% below the sector average

What The Brokers Say

Strong Buy 3
Buy 6
Neutral 13
Sell 1
Strong Sell 2
Total 25
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 23-Feb-23 17-Nov-22
Paid 13-Apr-23 12-Jan-23
Amount 13.75p 13.75p

Trades for 29-Mar-2023

Time Volume / Share Price
16:45 741 @ 1,417.00p
16:45 741 @ 1,417.00p
16:35 100 @ 1,420.60p
16:35 495 @ 1,420.60p
16:35 299 @ 1,420.60p

GSK Key Personnel

CEO Emma Walmsley
CFO Iain Mackay

Top of Page